KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Goodwill (2016 - 2025)

Elevance Health (ELV) has disclosed Goodwill for 17 consecutive years, with $28.5 billion as the latest value for Q3 2025.

  • On a quarterly basis, Goodwill rose 9.57% to $28.5 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $28.5 billion, a 9.57% increase, with the full-year FY2024 number at $28.3 billion, up 11.69% from a year prior.
  • Goodwill was $28.5 billion for Q3 2025 at Elevance Health, roughly flat from $28.4 billion in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $28.5 billion in Q3 2025 to a low of $21.7 billion in Q1 2021.
  • A 5-year average of $26.0 billion and a median of $25.9 billion in 2024 define the central range for Goodwill.
  • Biggest YoY gain for Goodwill was 11.7% in 2021; the steepest drop was 0.22% in 2021.
  • Elevance Health's Goodwill stood at $24.2 billion in 2021, then increased by 0.64% to $24.4 billion in 2022, then increased by 3.83% to $25.3 billion in 2023, then increased by 11.69% to $28.3 billion in 2024, then grew by 0.62% to $28.5 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Goodwill are $28.5 billion (Q3 2025), $28.4 billion (Q2 2025), and $28.4 billion (Q1 2025).